Outrage of the Month: Industry Lawsuit Threatens FDA's Regulation of Drugs
On May 7, Amarin Pharma filed an unusual lawsuit against the Food and Drug Administration (FDA), arguing that the agency's drug regulations violate the company's First Amendment free-speech rights. If Amarin prevails in its litigation, the repercussions for patient and public health will be dire.
outrage month industry lawsuit threaten fda regulation drug amarin pharma file unusual lawsuit food drug administration fda argue agency drug regulation violate company amendment free speech right amarin prevail litigation reperc USA on patient public health dire